Analyst Ryan MacDonald from Needham maintained a Buy rating on Phreesia (PHR – Research Report) and keeping the price target at $29.00. Discover outperforming stocks and invest smarter with Top ...

Analyst Price Forecast Suggests 8.40% Upside As of December 24, 2024, the average one-year price target for Phreesia is $30.82/share. The forecasts range from a low of $24.24 to a high of $37.80.

Phreesia, Inc. (NYSE:PHR), a leading healthcare technology company specializing in patient intake management and workflow optimization, has been garnering attention from analysts and investors ...

5 analysts have shared their evaluations of Phreesia (NYSE:PHR) during the recent three months, expressing a mix of bullish and bearish perspectives. The following table summarizes their recent ...

On Wednesday, RBC Capital Markets upgraded Phreesia Inc . (NYSE:PHR) stock, a leading healthcare software company, from Sector Perform to Outperform, with a new price target set at $32.00, up from the ...

DA Davidson analyst William Jellison keeps a Buy rating and $36 price target on Phreesia (PHR) while naming the company the firm’s 2025 top pick in Vertical Software. The stock remains “poorly ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...